| P50 | author | Susanne Walitza | Q37616108 |
| P2093 | author name string | Ulrike Held | |
| | Gregor Berger | |
| | Klaus Schmeck | |
| | Isabelle Häberling | |
| P2860 | cites work | The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes | Q46972058 |
| | Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials. | Q47235837 |
| | The measurement of pessimism: the hopelessness scale. | Q47359395 |
| | Variation in the 12-Month Treatment Trajectories of Children and Adolescents After a Diagnosis of Depression | Q47438099 |
| | The KIDSCREEN-52 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries | Q47723176 |
| | Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders | Q47736562 |
| | Fish consumption and major depression | Q47757469 |
| | Red blood cell fatty acids are associated with depression in a case-control study of adolescents | Q47959971 |
| | Pilot Randomized Controlled Trial of Omega-3 and Individual-Family Psychoeducational Psychotherapy for Children and Adolescents With Depression. | Q48036852 |
| | Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response | Q48082153 |
| | Depression trajectories, inflammation, and lifestyle factors in adolescence: The TRacking Adolescents' Individual Lives Survey | Q48091175 |
| | Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study | Q48372657 |
| | Omega-3 fatty acids on the forced-swimming test | Q48385318 |
| | Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion | Q48489400 |
| | Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial | Q48589289 |
| | Validation of the Insomnia Severity Index as an outcome measure for insomnia research | Q48689674 |
| | Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet | Q48738507 |
| | Association of high-sensitivity C-reactive protein with de novo major depression | Q48972863 |
| | alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. | Q49043298 |
| | Omega-3 fatty acids and major depression: a primer for the mental health professional | Q21245686 |
| | Omega-3 fatty acids and depression: scientific evidence and biological mechanisms | Q21284717 |
| | Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression | Q22305455 |
| | Variations in the Pattern of Pubertal Changes in Boys | Q24569516 |
| | Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine | Q24612175 |
| | Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis | Q24634019 |
| | Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports | Q26773320 |
| | Cognitive remission: a novel objective for the treatment of major depression? | Q26775386 |
| | ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review | Q28076799 |
| | A children's global assessment scale (CGAS) | Q28271291 |
| | Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment | Q28565110 |
| | Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects | Q28578394 |
| | A global measure of perceived stress | Q29547166 |
| | Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 |
| | Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion | Q30594357 |
| | Dual imputation model for incomplete longitudinal data | Q30658889 |
| | Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements | Q31050854 |
| | Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials | Q33578486 |
| | News coverage of FDA warnings on pediatric antidepressant use and suicidality | Q33584737 |
| | Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. | Q50528223 |
| | Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial. | Q50653409 |
| | Fish oil LC-PUFAs do not affect blood coagulation parameters and bleeding manifestations: Analysis of 8 clinical studies with selected patient groups on omega-3-enriched medical nutrition. | Q50713074 |
| | Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. | Q50786244 |
| | Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials. | Q51246512 |
| | A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. | Q51568336 |
| | Brief scale for measuring the outcomes of emotional and behavioural disorders in children. Health of the Nation Outcome Scales for children and Adolescents (HoNOSCA). | Q51978833 |
| | The Strengths and Difficulties Questionnaire: a pilot study on the validity of the self-report version. | Q51989505 |
| | Validity of the Childhood Trauma Questionnaire in an adolescent psychiatric population. | Q52003307 |
| | Hippocampal volume reduction in major depression. | Q52172075 |
| | Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. | Q55042041 |
| | Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids | Q59859017 |
| | Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression | Q60730988 |
| | How blind is double-blind? A study of fish oil versus placebo | Q74260482 |
| | Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics | Q77139535 |
| | Depressive spectrum disorders in high-risk adolescents: episode duration and predictors of time to recovery | Q77875489 |
| | [Children's Depression Rating Scale-Revised (CDRS-R): development of a German version and psychometric properties in a clinical sample] | Q84079155 |
| | Limitations of the review and meta-analysis of the role of n-3 long-chain PUFA supplementation and cognitive function | Q85275822 |
| | A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression | Q89473280 |
| | Efficacy of omega-3 PUFAs in depression: A meta-analysis | Q92431544 |
| | Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response. | Q46862603 |
| | Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia | Q33979893 |
| | A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids | Q34005609 |
| | Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder | Q34013923 |
| | Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. | Q34096721 |
| | EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials | Q34113501 |
| | Global burden of disease in young people aged 10-24 years: a systematic analysis | Q34190586 |
| | Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing | Q34319040 |
| | Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats | Q34393112 |
| | Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders | Q34432419 |
| | Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder | Q34449554 |
| | Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment | Q34454744 |
| | Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects | Q34465150 |
| | Understanding omega-3's | Q34497986 |
| | Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. | Q34523142 |
| | Linking Molecules to Mood: New Insight Into the Biology of Depression | Q34540304 |
| | Omega-3 fatty acids and mood disorders | Q34567965 |
| | Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials | Q34589381 |
| | A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. | Q34596621 |
| | Convergence of Children's Depression Rating Scale-revised Scores and Clinical Diagnosis in Rating Adolescent Depressive Symptomatology | Q34618926 |
| | The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. | Q35138239 |
| | Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology | Q35205824 |
| | Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. | Q35599565 |
| | Collaborative care for adolescents with depression in primary care: a randomized clinical trial | Q35821649 |
| | Screening for adolescent depression in a pediatric emergency department | Q36427668 |
| | Association between Blood Omega-3 Index and Cognition in Typically Developing Dutch Adolescents | Q36507414 |
| | Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology | Q36583969 |
| | Omega-3 fatty acids and monoamine neurotransmission | Q36590185 |
| | Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. | Q36915538 |
| | The role of fatty acids in the development and treatment of mood disorders | Q37087215 |
| | Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? | Q37183514 |
| | Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. | Q37244564 |
| | Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder | Q37338715 |
| | The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. | Q37624657 |
| | Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder. | Q37720606 |
| | A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression | Q37746266 |
| | Cytokines mediated inflammation and decreased neurogenesis in animal models of depression | Q37769871 |
| | Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain | Q37833540 |
| | Omega-3 fatty acids and depression: from cellular mechanisms to clinical care | Q37850514 |
| | Placebo effect in child and adolescent psychiatric trials | Q37949748 |
| | Challenging the public stigma of mental illness: a meta-analysis of outcome studies | Q38049071 |
| | Duration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysis | Q38158841 |
| | Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration | Q38170939 |
| | Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials | Q38269824 |
| | Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany | Q38469045 |
| | A depression rating scale for children | Q38556347 |
| | Sex differences in recent first-onset depression in an epidemiological sample of adolescents. | Q38757093 |
| | Dietary n-3 PUFA, fish consumption and depression: A systematic review and meta-analysis of observational studies | Q38932759 |
| | Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options | Q38967863 |
| | Enhancement of cell viability after treatment with polyunsaturated fatty acids | Q39057294 |
| | Effects of vegetable oils on biochemical and biophysical properties of membrane retinal pigment epithelium cells. | Q39076008 |
| | Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). | Q39266372 |
| | Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. | Q39456356 |
| | Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies | Q39457006 |
| | Diet-induced changes in iron and n-3 fatty acid status and associations with cognitive performance in 8-11-year-old Danish children: secondary analyses of the Optimal Well-Being, Development and Health for Danish Children through a Healthy New Nordi | Q40550840 |
| | Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: A preliminary randomized and placebo controlled trial | Q40721473 |
| | Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults | Q40745824 |
| | Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study. | Q40963212 |
| | Presentation and course of major depressive disorder during childhood and later years of the life span | Q41017525 |
| | Eating the right amount of fish: inverted U-shape association between fish consumption and cognitive performance and academic achievement in Dutch adolescents | Q42633097 |
| | Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis | Q42695616 |
| | Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study | Q42936138 |
| | The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. | Q43492519 |
| | Listening to the heart-brain talk: persistent depressive symptoms are associated with hsCRP in apparently healthy individuals at high risk for coronary artery disease | Q43500088 |
| | The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction | Q43691148 |
| | Mental health, educational, and social role outcomes of adolescents with depression | Q43905921 |
| | Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial | Q44168453 |
| | ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression | Q44202024 |
| | Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats | Q44208820 |
| | Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods | Q44411627 |
| | Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration | Q44827100 |
| | A black-box warning for antidepressants in children? | Q45106191 |
| | Fish consumption and depression: the Northern Finland 1966 birth cohort study | Q45157437 |
| | Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomised rats. | Q45850845 |
| | Childhood onset major depressive disorder: course of illness and psychiatric comorbidity in a community sample. | Q46037142 |
| | Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. | Q46774006 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 863 | |
| P577 | publication date | 2019-11-27 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study | |
| P478 | volume | 10 | |